Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication

We recently demonstrated that human p38 mitogen-activated protein kinase (MAPK) inhibitors reduced in vitro and in vivo replication of the protozoan parasites Toxoplasma gondii and Encephalitozoon cuniculi. In this study, we assessed the efficacy of five p38 MAPK inhibitors to block the replication...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Brumlik, Michael J., Nkhoma, Standwell, Kious, Mark J., Thompson, George R., Patterson, Thomas F., Siekierka, John J., Anderson, Tim J.C., Curiel, Tyler J.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3076546/
https://ncbi.nlm.nih.gov/pubmed/21338604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exppara.2011.02.016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares